Earn 2.0 AMA PRA Category 1 Credit(s)
TM
/ 2.0 AACN Contact Hours / 2.0 ACPE Contact Hours
Registration and Course are Fre...
Register Now. It’s Easy! It’s Free!
Community Updates in Oncology 2008:
A Focus on Multiple Myeloma
Please copy completed ...
Meeting Agenda
6:00PM–6:25PM Registration and Reception
6:25PM–6:30PM Welcome and Introduction Vivek S. Kavadi, MD
6:30PM–...
• Amend supportive care protocols to improve patient quality of life and maximize
treatment outcomes
• Summarize current t...
Upcoming SlideShare
Loading in...5
×

Earn 2.0 AMA PRA Category 1 Credit(s)

647

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
647
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Earn 2.0 AMA PRA Category 1 Credit(s)"

  1. 1. Earn 2.0 AMA PRA Category 1 Credit(s) TM / 2.0 AACN Contact Hours / 2.0 ACPE Contact Hours Registration and Course are Free Register NOW by printing and faxing the attached form OR CLICK HERE TO REGISTER Dear Colleagues, It is with great pleasure that we invite you to join us for an exciting educational activity, Community Updates in Oncology 2008: A Focus on Multiple Myeloma. This certified CME/CE accredited meeting offers an opportunity for community-based cancer caregivers to rapidly acquire knowledge of the most recent advances in cancer care. Designed to be multidisciplinary and interactive, this meeting will be facilitated by a physician from the practice who will stimulate and guide discussion of the latest data and their application through the presentation of select patient cases. An expert faculty will provide presentations on the latest practice-changing data and participate in the case discussions. Please refer to the agenda below for further meeting details, or e-mail Dawn Riggenbach at dawn.riggenbach@oncologytoday.com. On behalf of Texas Oncology Cancer Center-Sugar Land, we hope that you will join us as we provide a multidisciplinary perspective of the most up-to-date treatment options for patients with multiple myeloma and offer suggestions for their implementation into your practice. Sincerely, Texas Oncology Cancer Center-Sugar Land Oncology Today TM 16825 Northchase Drive, Suite 140, Houston, TX 77060
  2. 2. Register Now. It’s Easy! It’s Free! Community Updates in Oncology 2008: A Focus on Multiple Myeloma Please copy completed form and fax to: (832) 601-8872 or register online at: www.oncologytoday.com Texas Oncology Cancer Center-Sugar Land Office 1350 First Colony Boulevard (at Highway 6) Sugar Land, Texas 77479 (281) 277-5200 Wednesday, June 25, 2008 6:00PM-8:30PM Please Print: Name (First/Middle Initial/Last) Degree/Credentials Title Affiliation/Institution Address City State Zip Code Telephone Fax E-mail Specialty Special Assistance Needs For additional course information, please call Dawn Riggenbach at (866) 924-5290. Please reply by June 18, 2008 to guarantee your reservation, as space is limited. Physicians will be give priority registration. Confirmations will be sent via e-mail ONLY (e- mail will be used solely for confirmation purposes).
  3. 3. Meeting Agenda 6:00PM–6:25PM Registration and Reception 6:25PM–6:30PM Welcome and Introduction Vivek S. Kavadi, MD 6:30PM–6:50PM Presentation Updates in Treatment Options for Multiple Myeloma Henry C. Fung, MD 6:50PM–7:00PM Question & Answer 7:00PM–8:25PM Case Presentations and Discussion Faculty Panel and Participants 8:25PM–8:30PM Closing Remarks Robert Furse, MD Meeting Moderators and Guest Speaker Meeting Moderators Guest Speaker Vivek S. Kavadi, MD Radiation Oncologist Texas Oncology Cancer Center-Sugar Land Sugar Land, Texas Robert Furse, MD Medical Oncologist Texas Oncology Cancer Center-Sugar Land Sugar Land, Texas Henry C. Fung, MD Director, Section of Stem Cell Transplantation Professor of Medicine Rush University Medical Center Chicago, Illinois Overview With the constant evolution of oncology research, it is a significant challenge for community-based hematologists/oncologists to stay abreast of the most effective multiple myeloma treatment paradigms. Tumor board-styled dinner meetings have been proven as valuable, educational tools that enable cancer care professionals to assimilate the latest trends in hematology, oncology, and stem cell transplantation. Hosted by Texas Oncology Cancer Center-Sugar Land, this certified CME/CE, case-based meeting offers cancer-care providers the benefits of tumor boards including the opportunity to discuss difficult case vignettes presented by local physicians. The activity also features a lecture by a guest expert faculty in multiple myeloma patient care. Participants will take away a multidisciplinary opinion to assist in formulating and delivering optimal treatment strategies for their patients. Target Audience This continuing medical education meeting is intended for community-based hematologists, medical and surgical oncologists, and fellows. Internists, general/family practitioners, nurses, pharmacists, physician assistants, and mid-level practitioners involved in the care of multiple myeloma patients are encouraged to attend. Learning Objectives At the end of this meeting you should be able to: • Describe multidisciplinary treatment options for cancer patients • Discuss the benefits of a multidisciplinary treatment approach to cancer care
  4. 4. • Amend supportive care protocols to improve patient quality of life and maximize treatment outcomes • Summarize current treatment practices for patients with multiple myeloma • Implement new practices for patients with all stages of multiple myeloma • Discuss currently available clinical trials with appropriately selected patients Method of Instruction This meeting will be comprised of a lecture from a national expert in the field of multiple myeloma and two to four patient case-presentations provided by local physicians. Participants will have the opportunity to discuss both the cases and challenging patient management issues with the expert presenters and their colleagues. Accreditation: ACCME, AACN, and ACPE This meeting has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Texas Medical Branch at Galveston and Oncology Today. The University of Texas Medical Branch at Galveston (UTMB) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas Medical Branch at Galveston designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s) TM . Physicians should only claim credit commensurate with the extent of their participation in the activity. This meeting has been approved by the American Association of Critical Care Nurses (AACN) for 2.0 Contact Hours, Category A, File Number 2007- (1114). The University of Houston College of Pharmacy (UHCOP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing education. Pharmacists documenting completion of the meeting “Community Updates in Oncology 2008: A Focus on Myeloma” (# 066- 999-08-021-L01-P) by signing in and completing evaluations will receive 2.0 contact hours (0.2 CEU) pharmacy continuing education credit, and will receive a statement of credit by mail within 3 weeks of UHCOP being notified of the completion date. Policy on Disclosure It is the policy of the University of Texas Medical Branch at Galveston that the sponsors and faculty disclose real and apparent conflicts of interest relating to the topics of this educational activity. Detailed disclosure will be made in the syllabus of the course material. Special Assistance In compliance with the American Disabilities Act, the University of Texas Medical Branch and Oncology Today will make all reasonable efforts to accommodate persons with disabilities at this meeting. Please call (866) 924-5290 if you need special assistance. This certified CME/CE activity is supported by educational grants from: Celgene OrthoBiotech Millennium Pharmaceuticals, Inc.

×